Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 29;14(1):119.
doi: 10.1186/s13023-019-1091-8.

Research activity and capability in the European reference network MetabERN

Collaborators, Affiliations

Research activity and capability in the European reference network MetabERN

Jean-Michel Heard et al. Orphanet J Rare Dis. .

Abstract

Background: MetabERN is one of the 24 European Reference Networks created according to the European Union directive 2011/24/EU on patient's rights in cross border healthcare. MetabERN associates 69 centres in 18 countries, which provide care for patients with Hereditary Metabolic Diseases, and have the mission to reinforce research and provide training for health professionals in this field. MetabERN performed a survey in December 2017 with the aim to produce an overview documenting research activities and potentials within the network. As the centres are multidisciplinary, separated questionnaires were sent to the clinical, university and laboratory teams. Answers were received from 52 out of the 69 centres of the network, covering 16 countries. A descriptive analysis of the information collected is presented.

Results: The answers indicate a marked interest of the respondents for research, who expressed high motivation and commitment, and estimated that the conditions to do research in their institution were mostly satisfactory. They are active in research, which according to several indicators, is competitive and satisfies standards of excellence, as well as the education programs offered in the respondent's universities. Research in the centres is primarily performed in genetics, pathophysiology, and epidemiology, and focuses on issues related to diagnosis. Few respondents declared having activity in human and social sciences, including research on patient's quality of life, patient's awareness, or methods for social support. Infrastructures offering services for medical research were rarely known and used by respondents, including national and international biobanking platforms. In contrast, respondents often participate to patient registries, even beyond their specific field of interest.

Conclusions: Taken as a whole, these results provide an encouraging picture of the research capacities and activities in the MetabERN network, which, with respect to the number and representativeness of the investigated centres, gives a comprehensive picture of research on Hereditary Metabolic Diseases in Europe, as well as the priorities for future actions. Marginal activity in human and social sciences points out the limited multidisciplinary constitution of the responding teams with possible consequences on their current capability to participate to patient's empowerment programs and efficiently collaborate with patient's advocacy groups.

Keywords: European reference Centres; Hereditary metabolic diseases; Medical research activity; Multidisciplinary research.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Numbers of responses indicating « high », or « rather high » activity in the indicated field out of 122 answers

References

    1. Directive 2011/24/EU of the European Parliament and of the council of 9 march 2011 on the application of patients’ rights in cross-border healthcare http://data.europa.eu/eli/dir/2011/24/oj
    1. Heon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137. doi: 10.1186/s13023-017-0676-3. - DOI - PMC - PubMed
    1. Hannemann-Weber H, Kessel M, Schultz C. Research performance of centers of expertise for rare diseases--the influence of network integration, internal resource access and operational experience. Health Policy. 2011;105:138–145. doi: 10.1016/j.healthpol.2012.02.008. - DOI - PubMed
    1. Ayme S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50:1477–1483. doi: 10.1007/s00103-007-0381-9. - DOI - PubMed
    1. Ferreira C, van Karnebeek C, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2019;21:102–106. doi: 10.1038/s41436-018-0022-8. - DOI - PMC - PubMed

Publication types